AYTU
NASDAQ
$2.10
Aytu BioPharma Inc (AYTU)
Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and marketing novel products in the field of hypogonadism (low testosterone levels), cough and upper respiratory symptoms, insomnia, and male infertility in the United States and internationally. The company is headquartered in Englewood, Colorado.
Sector:
Healthcare
Strong Buy
Target: $9.33 (+344.29%)
Market Cap
$24M
P/B Ratio
0.67
Free Cash Flow Yield
6.04%
Price Chart
Valuation
Market Cap$24M
Forward P/E20.49
P/S0.41
P/B0.67
Profitability
Total Revenue (TTM)$57M
Gross Profit (TTM)$37M
EBITDA-$15M
Profit Margin-45.3%
Operating Margin-32.7%
EPS-$3.52
Financial Health
Debt-to-Equity32.5%
Free Cash Flow Yield6.04%
Growth & Risk
EPS 5Y CAGR-32.17%
Revenue 5Y CAGR+7.34%
Sharpe Ratio0.51